Spinal cord stimulation (SCS) may be a treatment option in limb ischemia occurring as a result of Thromboangiitis obliterans (TAO) or secondary Raynaud's-Syndrome (SRS). The impact of SCS on disease progression and micro-perfusion was prospectively evaluated during a follow-up (FU) of 4 years. Under SCS, a significant increase in trans-cutaneous oxygen tension (tcpO2) was observed in TAO and a significant increase in systolic perfusion pressure at plethysmography was observed in SRS. Complete limb preservation was achieved in all patients who had reduced tobacco consumption. SCS is an efficient therapeutic tool in TAO and SRS. Patient selection criteria are crucial for success.
No takes yet. Share an insight, caveat, or question.
Niclauss et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: